DEF 14AThe Ballot
4D Molecular Therapeutics, Inc. files DEF 14A
Filed Apr 13, 2022 · 4y ago · Accession 0001193125-22-104263
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Ticker
- FDMT
- CIK
- 1650648
- Form type
- DEF 14A
- Filing date
- Apr 13, 2022
- Report date
- May 23, 2022
- Document
- d276905ddef14a.htm
- Size
- 692 KB